iShares Biotechnology ETF (NASDAQ:IBB) Shares Sold by Regent Peak Wealth Advisors LLC

Regent Peak Wealth Advisors LLC trimmed its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 5.7% in the fourth quarter, Holdings Channel reports. The fund owned 2,005 shares of the financial services provider’s stock after selling 122 shares during the period. Regent Peak Wealth Advisors LLC’s holdings in iShares Biotechnology ETF were worth $265,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently made changes to their positions in IBB. Security National Bank of SO Dak boosted its stake in shares of iShares Biotechnology ETF by 0.7% during the 2nd quarter. Security National Bank of SO Dak now owns 10,461 shares of the financial services provider’s stock worth $1,436,000 after acquiring an additional 75 shares in the last quarter. SPC Financial Inc. increased its stake in iShares Biotechnology ETF by 2.4% in the third quarter. SPC Financial Inc. now owns 3,265 shares of the financial services provider’s stock valued at $475,000 after purchasing an additional 75 shares during the last quarter. Werba Rubin Papier Wealth Management increased its stake in shares of iShares Biotechnology ETF by 2.7% during the 3rd quarter. Werba Rubin Papier Wealth Management now owns 2,918 shares of the financial services provider’s stock valued at $425,000 after acquiring an additional 76 shares during the last quarter. Capital Investment Advisors LLC increased its holdings in shares of iShares Biotechnology ETF by 1.0% during the 4th quarter. Capital Investment Advisors LLC now owns 10,449 shares of the financial services provider’s stock worth $1,381,000 after buying an additional 99 shares during the last quarter. Finally, Prairie Wealth Advisors Inc. increased its stake in iShares Biotechnology ETF by 6.0% during the second quarter. Prairie Wealth Advisors Inc. now owns 1,765 shares of the financial services provider’s stock worth $242,000 after acquiring an additional 100 shares during the last quarter. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Down 0.2 %

IBB stock opened at $132.65 on Tuesday. The stock has a 50-day simple moving average of $136.32 and a 200-day simple moving average of $141.84. iShares Biotechnology ETF has a 1 year low of $123.60 and a 1 year high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The firm also recently declared a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were issued a $0.0624 dividend. The ex-dividend date of this dividend was Tuesday, December 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.